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Abstract 
Receptor-type protein tyrosine phosphatases (RPTPs) have been implicated as direct or indirect 
regulators of neurotrophin receptors (Trks). It remains less clear if and how such RPTPs might 
regulate Trk proteins in vivo during development. Here we present a comparative expression 
profile of RPTP genes and Trk genes during early stages of murine, dorsal root ganglion 
maturation. We find little if any specific, temporal mRNA co-regulation between individual 
RPTP and Ntrk genes between E12.5-E14.5. Moreover, a double fluorescent in-situ 
hybridization and immunofluorescence study of seven Rptp genes with Ntrks revealed 
widespread co-expression of RPTPs in individual neurons, but no tight correlation with Trk 
expression profiles. No Rptp is expressed in 100% of Ntrk1-expressing neurons, whereas at 
least 6 RPTPs are expressed in 100% of Ntrk2- and Ntrk3-expressing neurons. An exception is 
Ptpro, which showed very selective expression. Short hairpin RNA suppression of Ptprf, Ptprs 
or Ptpro in primary, E13.5 DRG neurons did not alter Trk signaling. We therefore propose that 
Trk signaling may not be simply dependent on rate-limiting regulation by individual RPTP 
subtypes during sensory neuron development. Instead, Trk signaling has the potential to be 
buffered by concurrent inputs from several RPTPs in individual neurons. 
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Abbreviations 
PTP  protein tyrosine phosphatase 
RPTP  receptor-like protein tyrosine phosphatase 
nrPTP  Non-receptor protein tyrosine phosphatase 
DRG  dorsal root ganglion 
shRNA short hairpin RNA 
PTK   protein tyrosine kinase 
NT  neurotrophin 
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1.  Introduction 
 
 Reversible protein phosphorylation plays a key role in cell signaling during neural 
development, with the neurotrophin receptor family of protein tyrosine kinases (PTKs), the 
Trks, being central in controlling neuronal survival, axonogenesis and synaptic plasticity 
(Chao, 2003; Huang and Reichardt, 2003; Takahashi et al., 2011; Thoenen, 1995). Trk 
malfunction also underlies diseases such as neuropathies, degenerative disorders and cancers 
and so it is important that we understand both their positive and negative regulation. 
 Upon neurotrophin (NT) binding, Trks homodimerize and autophosphorylate conserved 
intracellular Tyr residues (Segal and Greenberg, 1996). These represent docking sites for 
effectors that mediate signaling through phosphatidylinositol-3-kinase (PI3K)/Akt, 
phospholipase C-γ and the Ras/MAPK pathways (Kaplan and Miller, 2000; Ullrich and 
Schlessinger, 1990). Trk signaling can also be modulated by tyrosine dephosphorylation, 
through the actions of protein tyrosine phosphatases (PTPs). Over 100 PTP genes are known, 
with the classical cysteine-based PTPs categorized into 17 non-transmembrane (NPTPs) and 21 
receptor-like PTPs (RPTPs) (Alonso et al., 2004). In the past decade it has become clear that 
many PTPs can modify PTK signaling, either negatively or positively and can have key roles 
in development and in disease (Julien et al., 2011; Stoker, 2005; Tonks, 2006).  
 Many RPTPs are expressed selectively and at high levels in the CNS and PNS during 
neural development. These enzymes have roles in neuronal survival, synaptic plasticity, axon 
guidance and nerve regeneration (Burden-Gulley and Brady-Kalnay, 1999; Chilton and Stoker, 
2000; Ensslen-Craig and Brady-Kalnay, 2004; Johnson and Van Vactor, 2003; Sommer et al., 
1997; Stepanek et al., 2001; Sun et al., 2000; Wang and Bixby, 1999). Significantly, the 
mRNA expression of RPTPs strongly overlaps with Trk gene expression in neural tissues and 
both protein types are found in neurites and growth cones. Evidence for the regulation of Trks 
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by PTPs comes from several sources. PTP inhibitors can activate Trk signaling and prevent cell 
death in hippocampal neurons (Gerling et al., 2004), suggesting that PTPs can hold Trk 
signaling in check. Indeed a number of RPTPs directly or indirectly interact with Trk proteins 
in vitro and can alter their signaling properties in cultured cells. Downregulation of LAR 
signaling augments NGF-induced neurite outgrowth and activation of TrkA in PC12 cells (Tisi 
et al., 2000; Xie et al., 2006). LAR regulates TrkB signaling in hippocampal neurons, possibly 
indirectly through activation of pp60Src, which then activates TrkB (Yang et al., 2006 ; Yang 
et al., 2005). RPTPσ, a close relative of LAR, is expressed widely and dephosphorylates all 
three Trks in cultured cells (Faux et al., 2007). Over-expression of RPTPσ in chick sensory 
neurons also suppresses NGF-dependent neurite outgrowth, without affecting cell survival 
(Faux et al., 2007). Interestingly, RPTPσ-deficient mice suffer from defects in proprioception, 
supporting the hypothesis of a possible interaction of RPTPσ with TrkC (Batt et al., 2002; 
Elchebly et al., 1999; Meathrel et al., 2002; Wallace et al., 1999 ). RPTP-BK shows very 
specific expression in subgroups of neurons in DRGs and has been suggested to control the 
differentiation and axonogenesis of NT-3 and NGF-dependent neurons (Beltran et al., 2003). 
RPTP-BK-deficient mice show nociceptive sensory neurons deficits and abnormalities in 
axonal guidance from proprioceptors and nociceptors within the spinal cord (Gonzalez-Brito 
and Bixby, 2009). Lastly, it has been shown that RPTPζ and RPTPγ have a differential ability 
to affect Trk signaling and NGF-dependent neurite outgrowth in PC12 cells (Shintani et al., 
2001). Whereas RPTPγ-deficient mice do not show any abnormalities in NGF-induced neurite 
outgrowth, RPTPζ dephosphorylates Tyr residues in the activation loop of TrkA (Shintani and 
Noda, 2008) and there is elevated TrkA-phosphorylation in RPTPζ-deficient mice, with subtle 
nociceptive deficits (Lafont et al., 2009). RPTP-BR7 interacts with TrkA and dephosphorylates 
it, possible affecting its maturation (Noordman et al., personal communication). Lastly, non-
receptor PTPs such as SHP1 can also control Trk activity (Marsh et al., 2003). There is 
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therefore compelling evidence for regulatory interactions between PTPs and Trks from cell 
culture studies. However, although these studies suggest specific interactions of particular 
PTPs with Trks, it is not clear whether such specificity is required or occurs in vivo in 
developing neurons. This is exemplified by the fact that major perturbations in Trk activities, 
as judged by changes in neuronal numbers for example, either do not occur or are very subtle 
in mice deficient for single RPTP genes. It is not clear if this is due to functional redundancy in 
RPTPs. To begin to address this, we define for the first time the precise dynamics of RPTP and 
Trk gene expression in dorsal root ganglia (DRGs), during a critical period of neuronal 
development in vivo. DRGs contain populations of at least 20 different subclasses of neurons 
that depend on various combinations of Trk for their survival and differentiation (Buchman and 
Davies, 1993; Liebl et al., 1997). We analysed E12.5 to E14.5 in the mouse, a window 
encompassing key periods of neurogenesis for TrkA nociceptive, thermoceptive and 
pruriceptive neurons, following from earlier production of proprioceptive TrkC+ neurons and 
mechanoreceptive TrkB+ neurons (Huang and Reichardt, 2003; Kramer et al., 2006; 
Marmigere and Ernfors, 2007; Phillips and Armanini, 1996). We studied co-expression of PTP 
and Trks genes using both a QPCR analysis and co-in situ analysis. We also experimentally 
suppressed the expression of Pptrf, Ptprs and Ptpro in cultured E13.5 DRG neurons and 
examined biochemical responses downstream of Trk signaling .  
 Our data indicate extensive, overlapping expression of many PTPs in DRGs, with 
individual RPTP genes extensively overlapping with Trk gene expression. However, there is 
little evidence of tight, developmental co-regulation of individual RPTPs and Trks, although 
Ptpro is the most selectively co-expressed with TrkC and TrkB at E13.5. Lack of alteration in 
Trk signaling after individual RPTP suppression suggests that Trk proteins are likely buffered 
in their regulation by the actions of multiply, co-expressed RPTPs. 
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2.   Materials and Methods 
2.1  RNA preparation  
DRGs from E12.5, E13.5 and E14.6 CD-1 mouse embryos (48-65 DRG per embryo) were 
dissected and RNA extracted using the RNeasy® Lipid Tissue Kit (Qiagen) following 
manufacturer’s instructions. RNA purity (260/280 ratio) and concentration were measured 
using a NanoDrop ND-1000 Spectrophotometer and integrity was tested with an Agilent 
Bioanalyzer and the RNA 6000 Nano LabChip Kit. 1 µg of mRNA was reverse transcribed 
into cDNA using the iScript™cDNA Synthesis Kit (BioRad) following manufacturer’s 
instructions.  
2.2  Quantitative RT real-time PCR (qPCR) screen. For all primer details, see 
Supplementary Material. qPCR was performed in technical duplicates with biological 
triplicates in a 384-well-plate format. Each reaction contained 1.25 ng of cDNA, 2.5 µl primer 
pair and 5 µl of 2x QuantiTect® SYBR Green PCR Master mix (Qiagen) including HotStart 
Taq DNA polymerase, QuantiTect® SYBR Green PCR buffer, dNTP mix, SYBR Green I, 
ROX passive reference dye and RNase-free H2O. A LightCycler (ABI 7900HT Fast Real-Time 
PCR System) was used as follows: 95 ºC for 5 min; 40x (10 sec at 95 ºC, 30 sec at 60 ºC). 
Primer specificities were verified by dissociation curve analysis. The primers detected 94 PTP 
genes, Ntrk1, Ntrk2 and Ntrk3 and three housekeeping genes (HKGs): Psmb2, Hprt1 and Gps1 
(primer sequences are available upon request). For relative global gene expression analysis, 2-
ΔCT values were calculated with ΔCt = Ct (sample) - Mean Ct (average of three HKGs (Psmb2, 
Hrpt1 and Gps1)). NormFinder, a publicly available Microsoft® Excel® Visual Basic 
Application, was used to identify the optimal reference genes (Psmb2, Hrpt1 and Gps1) 
(Andersen et al., 2004; Schmittgen and Livak, 2008). The results were displayed as percentage 
of expression compared to the set of HKGs (% 2-ΔCT). For comparison and evaluation of global 
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gene expression, the mean of all three stages was calculated. Statistical analysis was performed 
with Prism 4 (GraphPad Software) using one-way analysis of variance (ANOVA) with the 
Tukey’s Multiple Comparison post-test. Data were categorized according to their p values as 
non-significant (ns) with p > 0.05, significant (∗) with 0.01 < p < 0.05, very significant (∗∗) 
with 0.001 < p < 0.01 and extremely significant (∗∗∗) with p < 0.001. 
2.3   Single and double in-situ hybridisation and immunofluorescence 
Single chromogenic and fluorescent ISH was performed on embryo sections. Embryos were 
fixed in 4%-paraformaldehyde/PBS, cryo-protected, embedded either in Cryo-M-bed O.C.T. 
(Bright Instrument Co.) or gelatine and sectioned at 11 µm. RNA probes were synthesized 
according to manufacturer’s instructions using DIG- or FITC labelled kits (Roche). Probes 
were denatured in pre-warmed (65 ºC) hybridization buffer (0.2 M NaCl, 5 mM EDTA, 10 
mM Tris-HCl pH 7.5, 5 mM NaH2PO4.2H2O, 5 mM Na2HPO4, 50% deionized formamide, 0.1 
mg/ml yeast tRNA, 10% dextran sulphate, 1x Denhardt's solution). The slides were incubated 
with the probe at 65ºC overnight, and then washed in MABT (100 mM maleic acid, 150 mM 
NaCl, 0.1% Tween-20, pH 7.5), then stringent 65 ºC washes for 30 min (0.3 M sodium citrate, 
3 M NaCl, 50% formamide, 0.1% Tween-20). Slides were blocked (2% blocking reagent 
(Roche), 10% heat inactivated sheep serum, MABT) for 1 hour, before binding with anti-DIG 
or anti-FITC antibody (Roche) overnight at 4 ºC. Alkaline phosphatase-conjugated-anti-
DIG/FITC Fab fragments (Roche) and horseradish peroxidase-conjugated anti-DIG/FITC Fab 
fragments (Roche) were used for chromogenic or fluorescent detection respectively. Slides 
were washed with MABT or PBS-T (PBS with 0.1% Triton x 100) for chromogenic or 
fluorescent detection respectively. For chromogenic detection, the slides were equilibrated in 
developing buffer (100 mM Tris pH 9.8, 100 mM NaCl, 50 mM MgCl2) and incubated with 
NBT and BCIP (Roche) in developing buffer containing 5% polyvenylalcohol for 1 hour to 
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overnight. For fluorescent detection the Tyramide Signal Amplification plus fluorescent 
system kit (PerkinElmer Life Sciences) was used following manufacturer’s instructions. For 
double fluorescent hybridization, DIG- and FITC-labelled RNA probes were hybridized 
together to the specimen. After the first colour reaction the reporter enzyme was deactivated 
for 30 min in 3% H2O2-PBS, before the second colour reaction. Slides were mounted in 
VectaMount™ or Vectashield® containing DAPI (Vector Laboratories) for chromogenic or 
fluorescent slides, respectively. Polyclonal TrkA-antibody (Upstate # 06-574), polyclonal 
TrkB-antibody (R&D; AF1494), polyclonal TrkC-antibody (R&D; AF1404), anti-goat Alexa 
Fluor 488 (Invitrogen; A-11055) and FluoroLink™Cy™3-labelled streptavidin (Amersham 
Biosciences; PA43001) were used. Pictures were recorded with a Zeiss Axiophot and Zeiss 
Imager.Z1 ApoTome. For standard immunofluorescence studies, slides were first blocked with 
1% BSA (Fraction V, Sigma Aldrich)/PBS/0.05% Triton X-100 for 15 min. Primary and 
biotinylated-secondary antibodies were added in the same buffer for 30-60 min each, followed 
by streptavidin-conjugated fluorophores. Manual cell counting was performed on digital 
images, focusing on neurons identified by their large, round nuclei (DAPI-stained). Between 
213 and 1510 neurons on 2 to 13 different pictures of randomly selected DRG regions from 
several embryos were counted for the Trk/Trk combinations and the RPTP/Trk combinations 
(Numbers are shown in Supplementary Table 1). The percentage of cells unambiguously 
positive for RPTP and/or Trk receptors was determined and SDs calculated. 
 
2.4  Templates for in-situ riboprobes 
The following riboprobes were gifted to us: Ptpra (Prof. Jeroen den Hertog (den Hertog et al., 
1993)) representing bp 342-1799 of NM_008980: Ptprd ( Dr. Wiljan Hendriks (Mizuno et al., 
1993; Schaapveld et al., 1998)), bp 2544-3956 of NM_001014288; Ptprf  (Dr. Wiljan 
Hendriks (Schaapveld et al., 1995)), bp 4712-6881 of NM_011213; Ptprg (Dr. Sheilla Harroch 
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(Lamprianou et al., 2006)), bp 460-1291 of NM_008981; Ptprk (Prof. Jan Sap (Sap et al., 
1994)) bp 262-2040 of NM_008983; Ptpro (Dr. Takahiko Shimizu (Tomemori et al., 2000)) bp 
522-2409 of NM_011216; Ptprr (Dr Wiljan Hendriks and Irene Chisini (Van Den 
Maagdenberg et al., 1999)), bp 301-1580 of NM_011217; Ptprs (Dr. Masato Ogata (Ogata et 
al., 1994)) bp 977-1142 of NM_011218. A cDNA encoding Rptpj was PCR amplified from 
DRGs of E13.5 CD-1 mouse embryos. The Rptpj antisense probe corresponds to bp 1889-3182 
of NM_08982. The riboprobe for Ptprm was generated by Dr. Claire Faux (Faux et al., 2007), 
detecting bp 471-1448 of NM_008984.  
 Ntrk1 cDNA (I.M.A.G.E. clone ID: 5256438) was used to generate a probe 
corresponding to bp 1321-2280 of NM_001033124. Ntrk2 cDNA (I.M.A.G.E. clone ID: 
5707891) was used to generate a probe corresponding to bp 793-1920 of transcript variant 1 
(NM_001025074). Ntrk3 cDNA (I.M.A.G.E. clone ID: 40110345) was used to make a probe 
corresponding to bp 707-1878 of transcript variant 2 (NM_182809). 
 
2.5   Primary murine embryonic DRG cultures 
DRGs were dissected from E13.5 CD-1 embryos and dissociated in Hank’s balanced salts 
(HBSS) medium (Invitrogen) containing 40 U/ml papain (Worthington), 2 µl/ml saturated 
NaHCO3, 0.7 mg/ml L-Cysteine (Sigma Aldrich) and 0.2 mg/ml DNaseI (Sigma Aldrich) for 
10 min at 37 ºC, then in HBSS containing 5mg/ml dispase type II (Sigma Aldrich) and 4 
mg/ml collagenase II (Sigma Aldrich) for 10 min at 37 ºC. DRGs were triturated with 23- and 
21-gauge needles, in complete DRG medium (Dulbecco’s modified Eagle’s medium, 1% 
Pen/Strep, 10% FCS, 50 ng/ml murine NGF (Promega), 25 ng/ml human recombinant BDNF 
(Insights Biotechnology Ltd.) and 25 ng/ml human recombinant NT-3 (Sigma Aldrich)). Cells 
were seeded in complete DRG medium on plates coated with poly-L-lysine and fibronectin 
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(Sigma Aldrich). One day after plating, the mitotic inhibitors 50 mM Floxuridine 
(Calbiochem®) and 150 mM Uridine (Sigma Aldrich) were added.  
 
2.6  Testing of lentiviral pseudotypes 
Dissociated DRG cells were seeded at 30% confluency on poly-L-lysine- and fibronectin-
coated plates. To assess the maximal, viral susceptibility of the cells, the cells were transduced 
at MOIs of 25, 50 and 100 with seven different pseudotyped lentiviruses expressing eGFP 
(pLNT/SFFV-eGFP-WPRE) (Demaison et al., 2002). The pseudotypes were: Vesicular 
Stomatitis Virus (VSVg), Baculovirus gp64 (gp64), Ebola Zaire (EboZ), Ross River Virus 
(RRV), Murine Leukaemia Virus – Amphotropic (MLV-A), Murine Leukaemia Virus-
Ecotropic (MLV-E) and Hanta virus. The MOIs were determined by measurement of the mass 
of HIV-1 p24 antigen in the lentiviral vector preparation using the Beckman Coulter HIV!1 
p24 antigen assay according to the manufacturer’s instructions (physical titration). The cells 
were cultured in NGF-containing (50 ng/ml) complete medium for 96 hours before fixation 
with 4% PFA and photographing. 
 
2.7   Production of shRNA-containing HIV-1-derived replication deficient lentiviruses 
HEK293T cells were co-transfected with 19.2 µg MISSION TRC lentiviral expression 
vector pLKO.1 containing shRNA directed against murine RPTP genes (Sigma Aldrich, 
(Moffat et al., 2006)), plus 28.8 µg envelope plasmid pCEE encoding the envelope 
glycoproteins for murine leukaemia virus ecotropic (MLV-E; originally obtained from 
Prof. Michael Green, University of Massachusetts) and 28.8 µg packaging plasmid 
pCMVΔR8.74; originally obtained from Prof. Luigi Naldini, Istituto Scientifico H, San 
Raffaele, Italy) per T175 cm2 flask using the CaCl2 method in media containing 25 µM 
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chloroquine. Virus were collected after 48 hours, filtered using 0.22 µm filters (Millipore) and 
concentrated in Amicon Ultra-15 Centrifugal Filter Devices (Millipore). The following 
MISSION lentiviral vectors were used, targeting murine Ptprf (TRCN0000029944 [SH1], 
TRCN0000029945 [SH2], TRCN0000029946 [SH3], TRCN0000029947 [SH4], 
TRCN0000029948 [SH5]), Ptpro (TRCN0000029984 [SH1], TRCN0000029985 [SH2], 
TRCN0000029986 [SH3], TRCN0000029987 [SH4], TRCN0000029988 [SH5]), Ptprs 
(TRCN0000029994 [SH1], TRCN0000029995 [SH2], TRCN0000029996 [SH3], 
TRCN0000029997 [SH4], TRCN0000029998 [SH5]). As a non-targeting control the pLKO.1-
puro vector containing a non-targeting shRNA sequence from Qiagen was used (kindly 
provided by Dr. Jörg Mueller). 
 
2.8  Lentivirus-mediated knockdown of RPTP genes  
Dissociated E13.5 DRG cells were plated in with poly-L-lysine- and fibronectin-coated plates 
and virally-transduced at an MOI of 5 with pLNT/SFFV-eGFP-WPRE virus. This titre 
efficiently infected the neuronal populations, similarly to that seen with the MOI of 25 used 
above. MISSION TRC viruses were prepared in the same manner and titres were assumed to 
be similar to the pLNT/SFFV-eGFP-WPRE virus. Infection with MISSION TRC viruses at 
estimated MOI of 5 proved sufficient to knock down target mRNAs. After 24 hours the cells 
were gently washed with PBS and cultured for 72 or 96 hours in DMEM supplemented with 
1% Pen/Strep, 10% FCS, 50 ng/ml murine NGF (Promega), 25 ng/ml human recombinant 
BDNF (Insights Biotechnology Ltd.) and 25 ng/ml human recombinant NT-3 (Sigma Aldrich), 
50 mM Floxuridine (Calbiochem®) and 150 mM Uridine (SigmaSigma Aldrich). Infected DRG 
cells were washed with PBS, lysed with 350 µl RLT buffer from the RNeasy® Plus Mini Kit 
(Qiagen) and RNA and proteins were extracted; each infection was done in triplicate wells of 
cells and triplicate cDNAs were generated. cDNA synthesis used QuantiTect® RT Kits 
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(Qiagen) and QPCR was performed in 96-well-plate format with QuantiFast® SYBR Green 
PCR Kits (Qiagen). The qPCR was run in technical duplicates on the 7500 Fast Real-Time 
PCR System (Applied Biosystems) as follows: stage 1, 95 ºC for 5 min; stage 2: 40 cycles (10 
sec at 95 ºC and 30 sec at 60 ºC). Dissociation curves (15 sec at 95 ºC, 15 sec at 60 ºC, 15 sec 
at 95 ºC) for each reaction were run to check primer specificity. Data were normalized to an 
endogenous reference gene (Psmb2) (ΔCT) and compared to a mock treated control sample 
(ΔΔCT) (Livak and Schmittgen, 2001). The results were displayed as percentage of expression 
relative to the control sample.  
 
2.9  Immunoblotting 
Total protein obtained by acetone precipitation from DRG extractions was separated by  
polyacrylamide gel electrophoresis (PAGE) and subjected to immunoblotting. Antibodies were 
used against p44/42 MAPK (Cell Signaling Technology # 9102), phospho p44/42 MAPK 
(E10; Cell Signaling Technology # 9106), phosphor-Akt (S473) (Cell Signaling Technology # 
4060), AKT (Cell Signaling Technology # 9272), pan-Trk (C-14; Santa Cruz), TrkA (Upstate 
06-574), TrkB (R&D; AF1494), TrkC (R&Dl AF1404), pTrkA (794) (designated pTrk*; 
detects c-terminal PLC-gamma1-binding site in rodent TrkA and more weakly in TrkC 
[V.Tchetchelnitski, unpublished data]; from Prof. M.Chao, Skirball Institute, NY, USA; 
(Rajagopal et al., 2004)), pTrkB (Y816) (designated pTrk**; detects c-terminal PLC-gamma1-
binding site in all rodent Trk forms [V.Tchetchelnitski, unpublished data]; from Prof. M.Chao, 
Skirball Institute, NY, USA; (Arevalo et al., 2006)), STAT3 (Cell Signalling; 9139), pSTAT 
(Y705) (Cell Signalling; 4113) and β tubulin (H-235; SantaCruz). HRP-conjugated secondary 
antibodies were from Dako Cytomation Denmark A/S.  
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3.   Results. 
 
3.1  Expression of PTP and Trk families in E12.5-E14.5 DRGs 
 
We carried out an mRNA expression analysis of E12.5, E13.5 and E14.5 DRGs from 
mouse embryos, to determine the relative expression of PTP and Ntrk1, 2 and 3 genes. This 
developmental period encompasses critical periods of neurogenesis (Marmigere!and!Ernfors,!2007) during which the relative Trk expression patterns change. We could thus determine 
whether or not PTP genes demonstrate potential temporal co-regulation with Trks. Messenger 
RNA was extracted from pooled forelimb and lumbar DRGs and subjected to real-time QPCR 
on a semi-automated platform. The platform contained triplicate primer sets targeting 98 PTP 
family members, plus primer sets for Ntrk1, Ntrk2 and Ntrk3 (see Methods). Three 
housekeeping genes (HKGs), Psmb2, Hprt1 and Gps1 were tested using NormFinder and 
selected as the most suitable reference genes. QPCR analyses were carried out on three 
independent sets of DRGs and the relative quantification is displayed as 2-ΔCT as a % of gene 
expression relative to average HKG levels. This provides good comparative analysis of gene 
expression between the three developmental stages and reasonably accurate estimates of the 
relative expression levels of each gene.  
Figure 1 shows the relative expression levels of Trk genes. Ntrk1 shows little net 
change between E12.5 and E14.5, but there is an apparent peak of expression at E13.5, albeit 
with larger experimental variation. Ntrk2 and Ntrk3 both show a steady, relative decline. These 
data broadly parallel the known changes in Trk-expressing neurons during this period of 
development (Ernsberger, 2009; Molliver and Snider, 1997; White et al., 1996), but there may 
also be a component of mRNA dilution as increased numbers of supporting cells develop. 
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 From the QPCR analysis of 98 PTP-related genes, Ptprf Ptprs, Ptprr, Ptp4a1, Ptp4a2, 
Pten and Dusp11, showed the strongest, relative expression levels (over 60% of the HKGs). 
Figure 1B shows RPTP gene data and Supplementary Figure 1 shows all other PTPs tested. 
30% of the genes tested were below 5% that of the HKG level. We confirmed independently 
that several RPTP genes close to the 5% threshold were in fact at the limit of detection by in 
situ hybridization. Also, although it is possible that such genes may be expressed more strongly 
but in few neurons, we think this is unlikely since Ptpro is expressed in only around 10% of 
neurons (see below), but is strongly detected by QPCR (Figure 1B). Genes below the 5% 
cutoff were not studied further. A single study of E12.5 mRNA on a GeneChip® Mouse Exon 
1.0 ST array (Affymetrix) was also carried out. Although no strict comparative analysis is 
possible, we noted that the relative expression levels and background thresholds of PTP genes 
was similar to that found by qPCR (data not shown).  
 As our main interest here was in the developmental relationship between RPTP and Trk 
genes, we focused initially on 13 RPTP genes above the 5% cutoff. The temporal expression 
profiles of these genes exhibit a mixed pattern when compared to Trk genes. Ptprg and Ptprr 
show similar patterns to Ntrk1, whereas Ptprk and Ptprm, whose expression levels are low to 
begin with, are most similar to Ntrk2 and 3 (Figure 1B). However, for Ptprg, Ptprk and Ptprm 
our subsequent in situ data argues against meaningful co-regulation of expression with Trks 
(see below). All other RPTP genes had temporal patterns distinct from any individual Trk gene 
and do not appear to be developmentally co-regulated with Trk genes at this broad level. 
   
3.2  In situ analysis 
To complement the QPCR data, we carried out in situ hybridization analysis of eleven 
RPTP genes in embryo trunk tissue sections. Seven genes were clearly expressed at all stages 
in DRGs, Ptpra, Ptprd, Ptprf, Ptprg, Ptpro, Ptprr, Ptprs (Figure 2), consistent with data found 
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in the Gene Paint database (www.genepaint.org). The Ptprz probes unfortunately did not 
provide an adequate signal and were not studied further. In the QPCR study (Figure 1) Ptprj, 
Ptprm and Ptprk were at borderline expression levels (5-10% of HSK), but showed similar 
temporal expression profiles to Ntrk2 or 3 (Figure 1B). However, the in situ data of these 
RPTPs did not match the selective expression patterns seen with Ntrk2- or 3-expressing 
neurons (Figure 2). These three genes also showed weak expression comparable to background 
signals across DRGs, between E12.5 and E14.5. Thus developmental co-regulation of these 
RPTP genes with Trk genes is not actually seen at a cellular level. Of the strongly-expressed 
genes, all but Ptpro showed extensive and fairly uniform expression across DRG neurons, 
indicating that numerous RPTPs must be co-expressed in most neurons. Ptpro in contrast 
exhibited highly selective expression in only a small subset, as described previously (Beltran et 
al., 2003) (Figure 2). We also analysed sagittal sections of E13.5 embryos, demonstrating over 
the brachial region that there was no obvious rostrocaudal variation in RPTP or Ntrk 
expression (Supplementary Figure 2). 
 
3.3  Co-expression of PTPs and Trks at a cellular level 
 Our next aim was to determine the co-expression patterns of RPTP and Trk genes at a 
cellular level. These data may provide better insight into whether particular RPTPs show finer, 
spatial co-regulation with Trks. We carried out a series of either dual fluorescence in situ 
hybridizations, or combined in situ/immunodetections at E13.5, to localize RPTP genes and 
either Trk mRNA or Trk proteins, respectively, at higher resolution. Where feasible, 
immunodetection was used in preference to in situ, in order to more easily discern the outline 
of the neurons; only the anti-TkA antibody was functional for this immunodetection in 
conjunction with in situ analysis. 
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Previously it was reported that at E11.5 the majority of lumbar DRG cells are TrkC+ 
and their proportion drops to less than 10% at E13 (Phillips and Armanini, 1996, White et al., 
1996, Farinas et al., 1998). Also, the proportion of TrkB neurons drops to around 8% at E13 
then remains constant, whereas at E13 and E15 80% of cells are TrkA +ve (Farinas et al., 
1998). In broad agreement with this, our expression analysis of Trk genes and proteins in 
E13.5 DRG showed similar percentages (Figure 3A-H). Co-expression analysis also 
demonstrated that means of 25% TrkB-expressing neurons, and 30% TrkC-expressing neurons, 
also co-expressed TrkA (Figure 3O). Also, a mean of 25% TrkB neurons co-expressed TrkC, 
and a mean of 15% TrkC neurons co-expressed TrkB (Figure 3O). The data confirm the 
diverse, combinatorial Trk expression patterns in neurons at this developmental stage.  
Ptpra, Ptprd, Ptprf, Ptprg, Ptpro, Prprr and Ptprs expression was then analysed 
alongside Ntrks/Trks in similar E13.5 DRG sections. The percentages of neurons that were 
unambiguously expressing an RPTP gene and/or a Trk receptor or mRNA, were calculated. 
Examples of these co-expression data are shown in Figure 4 and the quantitation is shown in 
Figure 5 (neuron counts are shown in Supplementary Table 1). We have characterized cells as 
being positive for a given gene/protein when we could clearly see in situ signal or 
immunostaining above general background signals. We acknowledge that low expression of 
some genes may also be present in other neurons. Several conclusions can nevertheless be 
drawn from these data:  
(1) Effectively all Ntrk2-expressing neurons co-expressed Ptpra, Ptprf, Ptprg, Prprr and Ptprs 
(Figure 5B). These RPTP genes are thus slightly overrepresented in Ntrk2 cells (compare 
total % representation for each RPTP gene in Figure 5A).  
(2) Ptpro was also expressed in 100% of Ntrk2 neurons, representing a major 
overrepresentation (only 12% total neurons express Ptpro; Figure 5A).  
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(3)Ptprd was expressed in 74% of Ntrk2 positive neurons. This is a modest underrepresentation 
(91% total neurons express Ptprd; Figure 5A).  
(4) Effectively all of the Ntrk3-expressing neurons express every RPTP gene, except Ptpro, 
which was found in 78% (Figure 5B). This is again an overrepresentation of all RPTP genes.  
(5) Ntrk1-expressing neurons express RPTP genes in a range of 5%-100%, but in a pattern that 
is broadly in line with the relative total percentage expression for each RPTP gene (Figure 5A).  
The Ptpro gene thus shows a particularly extreme, non-random pattern of co-expression, 
biased away from Ntrk1 neurons and towards Ntrk2/3 neurons. Ptpro is thus very skewed in its 
expression pattern with respect to Ntrk genes, at least at the in situ thresholds that we were 
examining. The data overall also show that Ptpra, Ptprf, Ptprg, Ptprd, Prprr and Ptprs largely 
follow a pattern of expression that is a fairly randomly distributed across the Ntrk1 population 
(Figure 5), with no clear evidence that these RPTP genes have a developmental relationship 
with Ntrk1. This does not hold true for Ntrk2/3 neurons, however, where all the RPTPs 
examined are significantly overrepresented, except for Ptprd in Ntrk2-expressing cells and 
Ptpro in Ntrk1/TrkA-positive cells. 
 
3.4  ERK and AKT activation state after shRNA knockdown of Ptprf, Ptprs and Ptpro 
 The above data show that numerous RPTPs are co-expressed in individual neurons. If 
there is redundancy of RPTP function, this may lead to TRK regulation being tolerant to the 
suppression of individual members. Our objective here was to determine whether individual 
suppression of three specific RPTPs would influence Trk signaling in cultured E13.5 neurons. 
Three RPTP genes, Prprf (encodes LAR), Ptprs (encodes PTPσ) and Ptpro (encodes PTP-BK) 
were chosen for targeting. LAR has a range of positive and negative effects on TRK enzymes 
in hippocampal neurons and DRG explants (Yang et al., 2005). In PC12 cells the 
downregulation of LAR increases NGF-mediated neurite outgrowth and augments 
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phosphorylation of TRKA targets ERK and AKT (Tisi et al., 2000; Xie et al., 2006). RPTPσ  
dephosphorylates all three Trks in HEK293T cells, and over-expression in chick DRG neurons 
suppresses NGF-dependent neurite outgrowth (Faux et al., 2007). The importance of PTP-BK 
in sensory neurons is apparent from Ptpro-deficient mice, which display nociceptive and 
proprioceptive abnormalities and decreases in TrkA-expressing neurons (Gonzalez-Brito and 
Bixby, 2009). RPTP-BK also interacts with and dephosphorylates TrkC (Hower et al., 2009). 
Thus, each RPTP gene has a track record of influencing Trk signaling.  
 Here we assessed whether their individual loss of function could enhance or alter ERK 
and AKT activation, major downstream effectors of TRK enzymes in neurons!(Kaplan!and!Miller,!2000). To do this, gene expression of Ptprf, Ptpro and Ptprs was experimentally 
suppressed using shRNA-expressing lentiviruses in primary cultures of DRG neurons. 
ShRNAs were introduced with MISSION TRC lentiviral vectors (Sigma Aldrich). As the 
viral tropism in primary DRGs was not known, we first tested infection efficiency with seven 
pseudotyped lentiviruses. In dissociated, E13.5 DRG cells, virus pseudotyped with MLV-E and 
VSVg proved to be the most efficient at transducing sensory neurons (Figure 6). All other 
viruses transduced non-neural cells preferentially. Cell death was not quantified after viral 
infections, but it appeared minimal and not markedly different from uninfected controls 
(Supplementary Fig. 3). 
 For each gene we present gene knockdown results from at least two different, gene-
specific shRNA hairpins and also a negative control, non-targeting hairpin (Qiagen; kindly 
provided by Dr. Jörg Mueller, University of Jena, Germany) (Figure 7). E13.5 neurons were 
infected with shRNA viruses after one day in culture, then cultured for 3-4 days in medium 
containing NGF, BDNF and NT-3; except for Ptprf shRNA experiments without mitotic 
inhibitors, which lacked NT-3. Two experiments were carried out each for Pptrf and Ptpro 
(Figure 7A-F), with and without mitotic inhibitors, and one experiment was done with Ptprs 
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with mitotic inhibitors (Figure 7G, 7H). The knockdown efficiencies of the small hairpins were 
assessed using qPCR, normalized to the Psmb2 HKG, and mRNA levels of an unrelated RPTP 
gene was also assessed as a further check for off-target effects. We confirmed specific Ptpr 
target gene suppression using qPCR, with average reductions of 29-69%, 78-81% and 88-94% 
for Ptprf, Ptprs and Ptpro, respectively (white columns, Figure 7). The non-specific reduction 
in mRNA levels in the unrelated Ptpr genes (black columns, Figure 7) ranged from 0%-42%, 
but in each case the specific target was reduced at least 3 fold more. The reduction in 
endogenous RPTP protein levels could not be analyzed due to lack of effective antibodies 
using the limited protein quantities available. Nevertheless, the significant degree of mRNA 
knockdown is still expected to correlate well with reductions in protein.  
 Cellular proteins could be co-extracted from the cultures along with mRNA, providing 
enough material for immunoblotting with sensitive antibodies against activated phospho-AKT 
and phospho-ERK1/2. The AKT kinase is a major executer of the PI3K pathway, mainly 
initiated by phosphorylated Y751 and also Y490 in the Trk receptors (Reichardt, 2006). ERK1 
(p44) and ERK2 (p42) are mediators of the classical RAS-MAPK pathway, initiated by Trk 
signaling mainly through phosphorylated Y490 residues. The levels of phopho-AKT and 
phospho-ERK proteins in shRNA-treated neurons did not reveal any significant or consistent 
changes compared to controls. This remained the case whether or not mitotic inhibitors had 
been used.  
 As further evidence that the suppression of RPTP expression did not affect Trk signaling, 
we analysed the phosphorylation state of the Trk proteins themselves, as well as another direct 
target, STAT3. STAT3 phosphorylation was not affected by shRNA treatments 
(Supplementary Figure 4). The Trk phosphorylation was more challenging to assess, given the 
very small amounts of protein available and the relatively poor sensitivity of the anti-phospho-
Trk antibodies. Nevertheless, our data again do not show evidence of any reproducible change 
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in Trk protein phosphorylation after reductions in Ptprs, Ptprf or Ptpro mRNA (Supplementary 
Figure 4). 
 These data therefore show collectively that even though we could individually reduce 
endogenous expression of Ptprf, Ptprs and Ptpro mRNAs, this does not detectably impact on 
major TRK signaling pathways or general survival in cultured E13.5 sensory neurons.  
 
 
4.  Discussion. 
 
 We have attempted to uncover potential relationships between neurotrophin receptors 
and the PTP gene family, in particular the RPTPs, in terms of developmental co-regulation and 
direct influences over Trk signaling in early murine sensory neurons. Previous studies have 
shown that a range of RPTPs can bind to Trks and alter their signaling in various cultured cells. 
Although it was known that RPTP genes are broadly expressed in developing DRGs, we 
wanted to understand in finer detail the nature of their co-expression with individual Trks. We 
report extensive expression of the PTP gene family in early DRGs, although there was no 
obvious temporal expression relationship between individual RPTP and Trk genes. Extensive 
co-expression of 6 RPTP genes was observed in 80-98% of Ntrk1-expressing neurons, with co-
expression of most of these RPTP genes in 100% of Ntrk2-expressing and Ntrk3-expressing 
neurons. The exception was Ptpro, whose strong expression was limited to around 12% of 
neurons, being underrepresented in Ntrk1-expressing cells and highly overrepresented in 
Ntrk2- and Ntrk3-expressing cells. These findings suggest that there exists great potential for 
extensive RPTP redundancy in controlling Trk pathways in neurons at this developmental 
stage. This is consistent with our findings from shRNA suppression of Ptprf, Ptprs and Ptpro. 
In cultured, primary sensory neurons we saw no significant alteration in several signaling 
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components downstream of Trk proteins, or in Trk phosphorylation itself, after depletion of the 
mRNAs for these genes individually. 
 The combined qPCR and ISH expression analyses on E12.5 - E14.5 DRGs demonstrated 
the dynamic and complex expression of Trks and PTPs over this period. All but 7 of the 
classical PTPs are significantly expressed, alongside all but 4 DUSP genes. During E12.5-
E14.5, we noted maintenance of Ntrk1 and relative decline of Ntrk2 and 3, a period during 
which neuronal subtypes are dynamically changing (Marmigere and Ernfors, 2007). Genes 
Ptprk and Ptprm showed similar expression profiles to Ntrks 2 and 3, however these genes did 
not correlate with Ntrk2 and Ntrk3 expression at the single cell level. Thus none of the RPTPs 
examined showed a tight and specific, temporal relationship with Trk genes. The RPTP genes 
studied were also in each case expressed in less than 100% of Ntrk1-expressing neurons, thus 
TrkA may require several RPTP subtypes as regulatory partners in these neurons. Ptpn1,2,4, 
showed some temporal similarity with Ntrk1 expression and it remains possible that such 
nrPTPs represent specific Trk regulators in these neurons (Araki et al., 2000; Fujita et al., 
2011; Marsh et al., 2003). 
 The situation with Ntrk2 and Ntrk3 is somewhat different than with Ntrk1. In neurons 
expressing these genes, individual RPTPs are expressed in most or all cells, suggesting that 
TrkB/C-expressing neurons express an even larger cohort of RPTPs than Ntrk1-expressing 
cells. The exemplar of this is Ptpro, which is expressed strongly in 12% of all neurons, but is 
in 100% of Ntrk2- expressing neurons and around 80% of Ntrk3-expressing neurons. There 
may therefore be a particular developmental reason for PTP-BK protein expression to be so 
biased towards TrkB- and TrkC-expressing cells. Ptpro is of particular interest in the context of 
DRG sensory neuron development, since it is the only RPTP gene to date whose function has 
been linked directly to developmental defects in early DRG development (Beltran et al., 2003). 
At E16 in mouse, Ptpro is expressed in 80% of TrkC proprioceptors, in agreement with our 
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data, but not in TrkB neurons. Ptpro is also expressed in a less defined proportion of TrkA-
expressing E16 nociceptors (Beltran et al., 2003). It is therefore of interest that we find strong 
Ptpro expression in 5% of TrkA, 78% of TrkC and 100% of TrkB neurons at E13.5. It is 
unclear why we see such a dramatically different pattern of Ptpro/Ntrk2 co-expression 
compared to Beltran and coworkers. Although technical differences in our methodologies may 
underlie this, it is equally possible that significant expression changes occur in 
mechanoreceptor neuron populations between E13.5 and E16. Ptpro-deficient mice show a 
small decrease in TrkA-expressing nociceptive neuron numbers and no change in TrkC neuron 
numbers. Such mice also have documented nociceptive and proprioceptive defects. We would 
suggest therefore that the decreased nociceptive neurons could be due in part to loss of the 5% 
of Ptpro/TrkA-expressing neurons we observe, and the proprioceptive defects from signaling 
changes in the 78% of Ptpro/Ntrk3 co-expressing neurons. It is also possible that a deficit in 
Ptpro prior to E16 could lead to altered functions in, or even loss of, some TrkB neurons, 
contributing to the animals’ behavioral deficits. Changes in numbers of TrkB mechanoreceptor 
precursors in Ptpro-null mice after birth have yet to be documented.  
 How loss of Ptpro might in turn induce loss of neurons remains to be determined. 
Conceivably this might not occur directly through Trks, since suppression of Prpro in E13,5 
neurons has no observable effect on Trk signaling. One caveat with our Ptpro shRNA study, is 
that only around one in 8 neurons might be strongly expressing Ptpro in culture. Nevertheless, 
Ptpro is expressed very strongly in these neurons, and lower-expressing Ptpro neurons also 
exist (V.T. data not shown, (Haworth et al., 1998)) and so we would still expect to detect 
signaling alterations. Overall, our gene suppression analysis of Ptprf, Ptprs and Ptpro in 
explanted sensory neurons points towards the possibility that these particular RPTPs do not 
have rate limiting control over Trk signaling. This is despite the fact that all three RPTPs have 
been documented as having such activity in culture (Faux et al., 2007; Hower et al., 2009; Tisi 
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et al., 2000; Xie et al., 2006; Yang et al., 2006 ; Yang et al., 2005). Our conclusion of course 
assumes that RPTP protein levels track the shRNA-enforced losses of mRNA.  
 Functional redundancy is often mentioned in the context of RPTPs and is supported by 
the fact that most KO mice have little obvious developmental phenotype and their DRG 
development appears normal when examined. Double RPTP mutant combinations, however, 
can exhibit more dramatic deficits, but where neuronal losses occur it is well after DRG 
establishment (Uetani et al., 2006). These murine studies alongside our data here, thus point 
towards either strong functional redundancy in these E13.5 neurons, or an actual lack of 
specific activity towards Trk signaling components at this stage of development. 
   
Conclusions 
 Our data show that the PTP family of genes is extensively represented in developing 
sensory neurons and that RPTP genes exhibit widespread overlap in expression patterns, with 
each other and with Ntrk genes in E12.5-E14.5 sensory neurons. This provides ample 
opportunities for shared, co-regulation of Trk signaling, or functional redundancy. Selective 
regulation of individual Trk types by individual RPTPs therefore becomes difficult to envisage 
in these developing neurons. Instead, co-regulation of Trks by multiple PTPs may be required 
in these early neurons as they develop into a wide range of distinct sensory subtypes with 
diverse central and peripheral targets.  
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7.  Figure Legends 
 
Figure 1.   qPCR analysis of Ntrk and RPTP gene expression during DRG development. 
A, Expression of Ntrk1, Ntrk2 and Ntrk3 was measured in murine embryonic DRGs at E12.5 
(left, blue bars), 13.5 (middle, red bars) and 14.5 (right, green bars) using qPCR arrays. B, 
RPTP gene expression was measured at E12.5 (black bars), 13.5 (dark grey) and 14.5 (light 
grey). In B, the most highly expressed genes are shown in the left-hand graph (scale 0-400%) 
and lesser-expressed genes in the right-hand graph. In A and B, results of the relative 
quantification analysis are displayed as mean 2-ΔCT as a percentage relative to the HKG 
expression. SD and statistical analysis (ANOVA) generate p values: > 0.05, non significant 
(ns); 0.01 < p < 0.05 (∗); 0.001 < p < 0.01 (∗∗); p < 0.001 (∗∗∗). 
 
Figure 2. Analysis of Ntrk and RPTP gene expression on transverse E13.5 mouse embryo 
sections. 
In situ hybridization was performed on transverse cryosections through the forelimb region of 
E12.5 mouse embryos, with riboprobes detecting each Ntrk gene and a range of RPTP genes. 
Sense probes provided no specific staining (not shown). Each panel shows a region at the 
brachial level (dashed line of sectioning in cartoon), with spinal cord and a pair of DRGs. 
 
Figure 3. Expression of Trk receptors in murine E13.5 DRG neurons. 
Indirect immunofluorescence (IF) (A, C, E) and fluorescent (FISH) detection (B, D, F) were 
performed on transverse cryosections of E13.5 DRGs. In A-F, left panels are low 
magnification, the middle and right panels show higher magnification without and with DAPI, 
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respectively. TrkA, TrkB and TrkC antibodies detected the ECD of the corresponding Trk 
receptor and the riboprobes detected all known Ntrk transcripts. G and H, the calculated 
percentages of neurons unambiguously positive for either Trk protein or Ntrk mRNA. I-E, 
Two colour FISH performed sequentially on transverse cryosections through E13 brachial 
DRGS, using all combinations of Ntrk1/2/3, except in I and K where TrkA antibody was used. 
I-M scale bar = 20 µm. Arrowheads in merged images indicate non-coexpressing neurons, 
whereas examples of coexpressing neurons are in insets. N, percentages of Trk coexpressing 
neurons in reference to all detected neurons. O, percentages of Trk coexpressing neurons 
amongst Trk coexpressing neurons only. SDs are included. In O the lighter tone columns 
represent two colour FISH and the darker columns, where present, indicate IF+FISH. The 
cellular counting procedure is described in the Materials and Methods. 
 
Figure 4. Co-expression of RPTPs and Trks in murine E13.5 DRG neurons. 
Fluorescence co-detection of Ptpr mRNA (green) with Ntrk mRNA (red) or TrkA protein (red) 
in transverse sections of brachial E13.5 DRGs. Examples are shown of (i) Ptpro combined 
with TrkA, Ntrk2 and Ntrk3, (ii) TrkA combined with Ptprd or Ptprr, and (iii) Ntrk2 combined 
with Ptprf. Arrows indicate coexpressing neurons (identified with large, round nuclei) and 
arrowheads indicate cells expressing only RPTP mRNA. Scale bar = 20 µm. 
 
Figure 5. Quantitation of RPTP and Trk Co-expression  
Double fluorescent IHC and IF-labelled E13.5 DRG neurons were identified as in Figure 4, 
and their expression of either Ptpr mRNAs or Trk mRNAs/proteins assessed as 
expressing/non-expressing. A, total proportions of Rptp-expressing neurons relative to total 
identified neurons. B, proportions of each Trk+ population that co-expressed a given Rptp 
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gene; TrkA/Ntrk1 (black bars), Ntrk2 (dark grey), Ntrk3 (light grey). C, proportions of each 
Ptpr-expressing neuronal population that co-expressed a given Trk gene/protein. Means with 
SD are shown, following the cellular counting procedure described in the Materials and 
Methods. 
 
Figure 6. Lentivirus pseudotype test on dissociated DRG neurons.  
Dissociated neurons from E13.5 DRG were infected with HIV1-derived eGFP-expressing 
lentiviruses (pLNT/SFFV-eGFP-WPRE), pseudotyped in envelopes from murine leukaemia 
virus (ecotropic (MLV-E), vesicular stomatosis virus (VSVg), amphotropic murine leukeamia 
virus (MLV-A), Ross River virus (RRV), Ebola Zire virus (EboZ), baculovirus gp64 (gp64) 
and Hanta virus. Scale bar = 10 µm. A, examples of cells infected with MLV-E and VSVg 
(phase and fluorescence images) at MOI of 100. B, viral transduction efficiency based on GFP-
positive cell counts. Three different MOIs were used, 25, 50 and 100 virus per cell.  
 
Figure 7.  Ptpr suppression and signaling in DRG neurons. 
Cultures of E13.5 sensory neurons were infected either with lentiviral vectors encoding 2-3 
different shRNA hairpins targeting a specific Ptpr gene, or a control vector encoding non-
specific shRNA (ctrl). QPCR was used to quantify the targeted mRNA (bar charts with white 
columns) or a non-targetted Ptpr mRNA (bar charts with black columns), A and B show two 
Ptpro targeting experiments; D and E show two Ptprf targeting experiments; G shows one 
Ptprs targeting experiment; each value represents a mean of technical duplicate samples. Cell 
cultures in A and D included mitotic inhibitors. QPCR was carried out 72-94 hr after infection; 
ctrl was taken as 100% for each gene). Protein co-extracted with mRNA was immunoblotted 
and probed for pERK1/2 and pAKT. No significant, relative differences in these signaling 
proteins were detected in shRNA-treated samples. 
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Supplementary Figure 1. qPCR analysis of PTP family gene expression, excluding Ptpr 
genes, during DRG development. 
A, Expression of PTP gene was measured in murine embryonic DRGs at the developmental 
stages E12.5 (black bars), 13.5 (dark grey bars) and 14.5 (light grey bars) using qPCR arrays 
(see Materials and Methods). Results of the relative quantification analysis are displayed as 
means of 2-ΔCT as a percentage relative to the HKG set. The genes are grouped into (A) non-
receptor PTPs (Ptpn genes), (B) dual specificity and atypical DSP genes (Dusp), and (C) other 
PTPs including PTENs, myotubularins and PRLs. SD and statistical analysis (ANOVA) 
generate p values: > 0.05, non significant (ns); 0.01 < p < 0.05 (∗); 0.001 < p < 0.01 (∗∗); p < 
0.001 (∗∗∗). The Ptpr gene data is shown in Figure 1. 
 
Supplementary Figure 2. Expression of Ntrk and Ptpr genes in E13.5 mouse DRGS, in 
sagittal sections. 
In situ hybridization of riboprobes against Ntrk1-3 and Ptprs, Ptprd, Ptprf, Ptprr and Ptpro, in 
E13.5 DRG tissues in sagittal tissue sections in the brachial region (rostral is top). No apparent 
differences in any of the expression patterns is observed rostrocaudally. 
 
Supplementary Figure 3. Phenotypes of lentivirally-infeced DRG neurons. 
Cultures of E13.5 sensory neurons were infected with lentiviral vectors encoding shRNA 
hairpins targeting specific Ptpr genes (see Figure 7). The shRNAs are coded SH1-8 as in 
Figure 7. The cells were photographed under phase contrast on the day of infection, then 24,72 
and 96 hr later. No apparent toxicity was evident in the infected cultures and no differences 
were seen comparing SH viruses and negative control virus (C). 
+
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Supplementary Figure 4.  Phosphorylation states of Trk proteins and STAT3 
DRG neuron cultures were infected with shRNA-encoding lentiviruses and proteins were 
extracted as described in the Materials and Methods. Immunoblotting was used to detect a 
range of Trk proteins and their phospho forms, as well as STAT3 and phospho-STAT3 (Y705). 
The samples, shRNA hairpins and mitotic inhibitor usage all correspond to those in Figure 7. 
pTrk* detects the c-terminal PLC-γ1-binding site in TrkA and TrkC, whereas pTrk** detects 
the same site in all three Trk forms (see Materials and Methods). Although the limiting amount 
of protein available in these samples approached the detection limits of the Trk and phospho-
Trk antibodies in some experiments, generating weak signals, these independent studies 
revealed no consistent alterations of either phospho-Trk or pSTAT3, irrespective of treatment 
with either negative control hairpins or PTP-specific hairpins. Molecular sizes are shown to the 
right of each immunoblot. 
 
 
 !
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Supplementary+Table+1.+
+
+
Probes+used+ Sections+
analysed+
Total+
Neurons+
counted+Ntrk1!+!Ntrk2! ! ! ! 7! 805!Ntrk1!+!Ntrk3! ! ! ! 5! 526!TrkA+Ntrk2! ! ! (IMSITU)! 10! 1176!TrkA+!Ntrk3! ! ! (IMSITU)! 13! 1510!Ntrk2!+!Ntrk3! ! ! ! 3! 213!! ! !TrkA!+!Ptpro! ! ! (IMSITU)! 13! 1373!TrkA!+!Ptprs! ! ! (IMSITU)! 6! 619!TrkA!+!Ptprf! ! ! (IMSITU)! 5! 470!TrkA!+!Ptprd! ! ! (IMSITU)! 8! 924!TrkA!+!Ptprr! ! ! (IMSITU)! 4! 470!TrkA!+!Ptpra! ! ! (IMSITU)! 6! 710!TrkA!+!Ptprg! ! ! (IMSITU)! 7! 892!! ! !Ntrk2!+!Ptpro! 9! 996!Ntrk2!+!Ptprs! 2! 249!Ntrk2!+!Ptprf! 4! 389!Ntrk2!+!Ptprd! 4! 532!Ntrk2!+!Ptprr! 3! 282!Ntrk2!+!Ptpra! 4! 502!Ntrk2!+!Ptprg! 5! 479!! ! !Ntrk3!+!Ptpro! 11! 1184!Ntrk3!+!Ptprs! 5! 613!Ntrk3!+!Ptprf! 5! 534!Ntrk3!+!Ptprd! 6! 568!Ntrk3!+!Ptprr! 11! 1244!Ntrk3!+!Ptpra! 5! 567!Ntrk3!+!Ptprg! 5! 533!!Summary!of!the!neuron!counts!used!to!generate!graphs!in!Figures!3!and!5!of!the!main!text.!Each!coPexpression!pair!represents!doublePin!situ!hybridization,!unless!otherwise!stated.!IMSITU!represents!immunostaining!for!TrkA!protein!plus!in!situ!hybridization!for!the!second!probe.! !! !
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